Therapeutic options for nocturnal problems in Parkinson's disease and atypical parkinsonian disorders

Journal of Neural Transmission

Volumn 121, Issue SUPPL. 1, 2014, Pages

  Klingelhoefer, Lisa ^a,b   Sokolov, Elisaveta ^a   Chaudhuri, K Ray ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Atypical parkinsonian disorders, MSA, PSP; Nocturnal problems; Parkinson's disease; Sleep disturbance

Indexed keywords

HUMAN; PARKINSON DISEASE; PARKINSONIAN DISORDERS; PATHOPHYSIOLOGY; SLEEP DISORDERS;

HUMANS; PARKINSON DISEASE; PARKINSONIAN DISORDERS; SLEEP DISORDERS;

EID: 84905090893     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-014-1202-6     Document Type: Article

References (58)

1. Arnulf I (2005) Excessive daytime sleepiness in parkinsonism. Sleep Med Rev 9(3):185-200
2. Arnulf I, Merino-Andreu M et al (2005) REM sleep behavior disorder and REM sleep without atonia in patients with progressive supranuclear palsy. Sleep 28(3):349-354 (Pubitemid 40315572)
3. Aurora RN, Zak RS et al (2010) Best practice guide for the treatment of REM sleep behavior disorder (RBD). J Clin Sleep Med 6(1):85-95
4. Bhidayasiri R, Truong DD (2012) Therapeutic strategies for nonmotor symptoms in early Parkinson's disease: the case for a higher priority and stronger evidence. Parkinsonism Relat Disord 18(Suppl 1):S110-S113
5. Boeve BF, Silber MH et al (2001) Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Mov Disord 16(4):622-630
6. Boeve BF, Silber MH et al (2007) Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain 130(Pt 11):2770-2788 (Pubitemid 350033955)
7. Chaudhuri KR (2002) The basis for day and night-time control of symptoms of Parkinson's disease. Eur J Neurol 9(Suppl 3):40-43
8. Chaudhuri KR, Schapira AH (2009) Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. Lancet Neurol 8(5):464-474
9. Chaudhuri KR, Pal S et al (2002) The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease. J Neurol Neurosurg Psychiatry 73(6):629-635 (Pubitemid 35448845)
10. Epstein LJ, Kristo D et al (2009) Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med 5(3):263-276
11. Fantini ML, Gagnon JF et al (2003) The effects of pramipexole in REM sleep behavior disorder. Neurology 61(10):1418-1420 (Pubitemid 37463382)
12. Findley L, Smith C et al (2000) Treatment with nasal CPAP decreases automobile accidents in patients with sleep apnea. Am J Respir Crit Care Med 161(3 Pt 1):857-859 (Pubitemid 30171742)
13. Gagnon JF, Postuma RB et al (2006) Rapid-eye-movement sleep behaviour disorder and neurodegenerative diseases. Lancet Neurol 5(5):424-432
14. Gaig C, Iranzo A (2012) Sleep-disordered breathing in neurodegenerative diseases. Curr Neurol Neurosci Rep 12(2):205-217
15. Gama RL, Tavora DG et al (2010) Sleep disturbances and brain MRI morphometry in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy - a comparative study. Parkinsonism Relat Disord 16(4):275-279
16. Garcia-Borreguero D, Ferini-Strambi L et al (2012) European guidelines on management of restless legs syndrome: report of a joint task force by the European Federation of Neurological Societies, the European Neurological Society and the European Sleep Research Society. Eur J Neurol 19(11):1385-1396
17. Ghorayeb I, Yekhlef F et al (2002) Sleep disorders and their determinants in multiple system atrophy. J Neurol Neurosurg Psychiatry 72(6):798-800 (Pubitemid 34557028)
18. Hattori Y, Hattori T et al (2003) Excessive daytime sleepiness and low CSF orexin-A/hypocretin-I levels in a patient with probable progressive supranuclear palsy. No To Shinkei 55(12):1053-1056 (Pubitemid 38197113)
19. Hauw JJ, Hausser-Hauw C et al (2011) Neuropathology of sleep disorders: a review. J Neuropathol Exp Neurol 70(4):243-252
20. Hogl B, Saletu M et al (2002) Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial. Sleep 25(8):905-909 (Pubitemid 35424536)
21. Iranzo A (2005) Management of sleep-disordered breathing in multiple system atrophy. Sleep Med 6(4):297-300
22. Iranzo A, Santamaria J (1999) Bisoprolol-induced rapid eye movement sleep behavior disorder. Am J Med 107(4):390-392 (Pubitemid 29465818)
23. Iranzo A, Santamaria J et al (2000) Continuous positive air pressure eliminates nocturnal stridor in multiple system atrophy. Barcelona Multiple System Atrophy Study Group. Lancet 356(9238):1329-1330
24. Iranzo A, Santamaria J et al (2004) Long-term effect of CPAP in the treatment of nocturnal stridor in multiple system atrophy. Neurology 63(5):930-932 (Pubitemid 39297666)
25. Iranzo A, Molinuevo JL et al (2006) Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol 5(7):572-577 (Pubitemid 43867426)
26. Iranzo A, Santamaria J et al (2009) The clinical and pathophysiological relevance of REM sleep behavior disorder in neurodegenerative diseases. Sleep Med Rev 13(6):385-401
27. Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14(6):540-545
28. Kimura K, Tachibana N et al (1997) Subclinical REM sleep behavior disorder in a patient with corticobasal degeneration. Sleep 20(10):891-894 (Pubitemid 27524719)
29. Knie B, Mitra MT et al (2011) Excessive daytime sleepiness in patients with Parkinson's disease. CNS Drugs 25(3):203-212
30. Kuzniar TJ, Morgenthaler TI et al (2009) Effects of continuous positive airway pressure on stridor in multiple system atrophysleep laryngoscopy. J Clin Sleep Med 5(1):65-67
31. Larsen JP, Tandberg E (2001) Sleep disorders in patients with Parkinson's disease: epidemiology and management. CNS Drugs 15(4):267-275 (Pubitemid 32337050)
32. Montplaisir J, Petit D et al (1997) Sleep and quantitative EEG in patients with progressive supranuclear palsy. Neurology 49(4):999-1003 (Pubitemid 27456077)
33. Moreno-Lopez C, Santamaria J et al (2011) Excessive daytime sleepiness in multiple system atrophy (SLEEMSA study). Arch Neurol 68(2):223-230
34. Morrison I, Frangulyan R et al (2011) Beta-blockers as a cause of violent rapid eye movement sleep behavior disorder: a poorly recognized but common cause of violent parasomnias. Am J Med 124(1):e11
35. Olson EJ, Boeve BF et al (2000) Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. Brain 123(Pt 2):331-339 (Pubitemid 30055156)
36. Ondo WG, Fayle R et al (2005) Modafinil for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trial. J Neurol Neurosurg Psychiatry 76(12):1636-1639 (Pubitemid 41697625)
37. Ondo WG, Perkins T et al (2008) Sodium oxybate for excessive daytime sleepiness in Parkinson disease: an open-label polysomnographic study. Arch Neurol 65(10):1337-1340
38. Pahwa R, Stacy MA et al (2007) Ropinirole 24-hour prolonged release: randomized, controlled study in advanced Parkinson disease. Neurology 68(14):1108-1115 (Pubitemid 46559844)
39. Pao WC, Boeve BF et al (2013) Polysomnographic findings in dementia with Lewy bodies. Neurologist 19(1):1-6
40. Poewe WH, Rascol O et al (2007) Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial. Lancet Neurol 6(6):513-520 (Pubitemid 46734759)
41. Poewe W, Rascol O et al (2011) Extended-release pramipexole in early Parkinson disease: a 33-week randomized controlled trial. Neurology 77(8):759-766
42. Politis M, Wu K et al (2010) Parkinson's disease symptoms: the patient's perspective. Mov Disord 25(11):1646-1651
43. Ray Chaudhuri K, Martinez-Martin P et al (2012) Improvements in nocturnal symptoms with ropinirole prolonged release in patients with advanced Parkinson's disease. Eur J Neurol 19(1):105-113
44. Sasai T, Matsuura M et al (2013) Factors associated with the effect of pramipexole on symptoms of idiopathic REM sleep behavior disorder. Parkinsonism Relat Disord 19(2):153-157
45. Schapira AH, Barone P et al (2011) Extended-release pramipexole in advanced Parkinson disease: a randomized controlled trial. Neurology 77(8):767-774
46. Seppi K, Weintraub D et al (2011) The Movement Disorder Society Evidence-Based Medicine Review Update: treatments for the non-motor symptoms of Parkinson's disease. Mov Disord 26(Suppl 3):S42-S80
47. Shimohata T, Shinoda H et al (2007) Daytime hypoxemia, sleep-disordered breathing, and laryngopharyngeal findings in multiple system atrophy. Arch Neurol 64(6):856-861 (Pubitemid 46919841)
48. Shimohata T, Ozawa T et al (2008) Frequency of nocturnal sudden death in patients with multiple system atrophy. J Neurol 255(10):1483-1485
49. Shimohata T, Nakayama H et al (2012) Daytime sleepiness in Japanese patients with multiple system atrophy: prevalence and determinants. BMC Neurol 12:130
50. Silber MH, Levine S (2000) Stridor and death in multiple system atrophy. Mov Disord 15(4):699-704 (Pubitemid 30479623)
51. Stocchi F, Vacca L et al (2001) Sleep disorders in Parkinson's disease. Adv Neurol 86:289-293
52. Suzuki M, Saigusa H et al (2010) Multiple system atrophy manifesting as complex sleep-disordered breathing. Auris Nasus Larynx 37(1):110-113
53. Trenkwalder C, Kies B et al (2011) Rotigotine effects on early morning motor function and sleep in Parkinson's disease: a double-blind, randomized, placebo-controlled study (RECOVER). Mov Disord 26(1):90-99
54. Trenkwalder C, Kies B et al (2012) Rotigotine transdermal system for the management of motor function and sleep disturbances in Parkinson's disease: results from a 1-year, open-label extension of the RECOVER study. Basal Ganglia 2:79-85
55. Wilson SJ, Nutt DJ et al (2010) British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. J Psychopharmacol 24(11):1577-1601
56. Yamaguchi M, Arai K et al (2003) Laryngeal stridor in multiple system atrophy. Eur Neurol 49(3):154-159 (Pubitemid 36359464)
57. Yamauchi K, Takehisa M et al (2003) Levodopa improved rapid eye movement sleep behavior disorder with diffuse Lewy body disease. Gen Hosp Psychiatry 25(2):140-142 (Pubitemid 36379229)
58. Zesiewicz TA, Sullivan KL et al (2010) Practice Parameter: treatment of nonmotor symptoms of Parkinson disease: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 74(11):924-931